Pentwater Capital Management’s Acceleron Pharma Inc. XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-1,050,000
| Closed | -$181M | – | 229 |
|
|
2021
Q3 | $181M | Buy |
+1,050,000
| New | +$181M | 1.84% | 12 |
|
|
2015
Q4 | – | Sell |
-96,771
| Closed | -$2.41M | – | 95 |
|
|
2015
Q3 | $2.41M | Sell |
96,771
-115,229
| -54% | -$2.87M | 0.02% | 65 |
|
|
2015
Q2 | $6.71M | Buy |
212,000
+130,000
| +159% | +$4.11M | 0.04% | 64 |
|
|
2015
Q1 | $3.12M | Buy |
82,000
+2,000
| +3% | +$76.1K | 0.02% | 71 |
|
|
2014
Q4 | $3.12M | Buy |
+80,000
| New | +$3.12M | 0.02% | 66 |
|